Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | Date | No Grouping
Number of items: 6.

Journal Article

Ahmadzadehfar, H., Albers, P., Bockisch, A., Boegemann, M., Boehme, C., Burchert, W., Dietlein, M., Drzezga, A., Fabry, U., Feldmann, G., Heidenreich, A., Heinzel, A., Herrmann, K., Heyll, A., Hoehling, C., Kreuzer, C., Laufer, D., Mengel, R., Mottaghy, F. M., Mueller, H-W., Mueller, S. C., Ost, E., Rahbar, K., Reifenhaeuser, W., Schaefers, M., Schlenkhoff, C., Schmidt, M., Schmidt-Wolf, I., Wildenhain, C., Zimmer, B. and Essler, M. (2018). Lutetium-177-PSMA radioligand therapy. Consensus within the framework of GKV-funded care between the university hospitals in Aachen, Bonn, Dusseldorf, Essen, and Cologne and the MDK Nordrhein. Urologe, 57 (6). S. 709 - 714. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1433-0563

Gschwend, J. E., Albers, P., Boegemann, M., Goebell, P., Heidenreich, A., Klier, J., Koenig, F., Machtens, S., Pantel, K. and Thomas, C. (2018). Metastatic castration-resistant prostate cancer. Use of cabazitaxel taking into consideration current data. Urologe, 57 (1). S. 34 - 40. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1433-0563

Schostak, M., Koenig, F., Boegemann, M., Goebell, P., Hammerer, P., Machtens, S., Schwentner, C., Thomas, C., von Amsberg, G., von Rundstedt, F. -C. and Heidenreich, A. (2018). Advanced Prostate Cancer Consensus Conference 2017. Discussion of the recommendations for diagnosis and treatment of metastatic prostate cancer by a German panel of experts. Urologe, 57 (7). S. 813 - 821. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1433-0563

Smith, M. R., Parker, C. C., Saad, F., Miller, K., Tombal, B., Ng, Q. S., Boegemann, M., Matveev, V., Piulats, J. M., Zucca, L. E., Heidenreich, A., Kakehi, Y., Zhang, A., Krissel, H., Shen, J., Wagner, V. and Higano, C. (2018). ERA 223: A phase III trial of radium-223 (Ra-223) in combination with abiraterone acetate and prednisone/prednisolone for the treatment of asymptomatic or mildly symptomatic chemotherapy-naive patients (pts) with bone-predominant metastatic castration-resistant prostate cancer (mCRPC). Ann. Oncol., 29. OXFORD: OXFORD UNIV PRESS. ISSN 1569-8041

Thomas, C., Boegemann, M., Koenig, F., Machtens, S., Schostak, M., Steuber, T. and Heidenreich, A. (2016). Advanced Prostate Cancer Consensus Conference (APCCC) 2015 in St. Gallen. Critical review of the recommendations on diagnosis and therapy of metastatic prostate cancer by a German expert panel. Urologe, 55 (6). S. 772 - 783. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1433-0563

Wuelfing, C., Boegemann, M., Goebell, P. J., Hammerer, P., Machtens, S., Pfister, D., Schwentner, C., Steuber, T., von Amsberg, G. and Schostak, M. (2019). Treatment situation in metastastic Castration Naive Prostate Cancer (mCRPC) and the implications on clinical routine. Urologe, 58 (9). S. 1066 - 1073. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1433-0563

This list was generated on Fri Apr 26 11:37:14 2024 CEST.